Swissmedic licence

Novartis Pharma AG Technical Research & Development WSJ-042, 114, 145, 174, 177, 187, 360 WKL-405, 1372

Swissmedic licence 511511-102759243 · Basel · COMPLIANT

Key facts

Authorization number 511511-102759243
Licence holder Novartis Pharma AG
Site Novartis Pharma AG Technical Research & Development WSJ-042, 114, 145, 174, 177, 187, 360 WKL-405, 1372
City Basel
Canton BS
Country Switzerland
Compliance status COMPLIANT
Last inspection Jul 12, 2023
Valid until Indefinite
Manufacturing activities 1 MANUFACTURE OF MEDICINAL PRODUCTS (WITHOUT LABILE BLOOD PRODUCTS), 1.1 Sterile Products, 1.1.3 Batch certification (technical release) (I), 1.2 Non-sterile products, 1.2.1 Non-sterile products (processing operations for the following dosage forms), 1.2.1.1 Capsules, hard shell (I), 1.2.1.8 Other solid dosage forms (I), 1.2.1.13 Tablets (I), 1.2.1.17 Other non-sterile medicinal product: PLGA-Microparticles (I), 1.2.2 Batch certification (technical release) (I), 1.5 Packaging, 1.5.1 Primary packaging and 8 more
Wholesale activities S.4 WHOLESALE DISTRIBUTION OF MEDICINAL PRODUCTS (WITHOUT LABILE BLOOD PRODUCTS), S.4.1 Wholesale distribution of non- ready-to-use medicinal products, S.4.1.1 Medicinal products (intermediates, without immunological and blood products) (H/V,I), S.4.1.2 Immunological products (intermediates) (H/V,I), S.4.1.4 Active substances (H/V,I), S.4.3 Wholesale distribution of ready-to-use medicinal products, excluding market release, S.4.3.1 Medicinal products (without immunological and blood products) (H/V,I), S.4.3.2 Immunological products (H/V,I), S.4.6 Outsourcing of manufacture of medicinal products as contract giver (H/V,I)
Import activities S.2 IMPORT OF MEDICINAL PRODUCTS (WITHOUT LABILE BLOOD PRODUCTS), S.2.1 Import of non- ready-to-use medicinal products, S.2.1.1 Medicinal products (intermediates, without immunological and blood products) (H/V,I), S.2.1.2 Immunological products (intermediates) (H/V,I), S.2.1.4 Active substances (H/V,I), S.2.3 Import of ready-to-use medicinal products, excluding market release, S.2.3.1 Medicinal products (without immunological and blood products) (H/V,I), S.2.3.2 Immunological medicinal products (H/V,I), S.2.3.4 The import of ready-to-use medicinal products, excluding market release, is restricted to:, S.2.3.4.4 the import of medicinal products for clinical trials on behalf of the sponsor for subsequent distribution to the trial centres (H/V,I), S.2.6 Outsourcing of manufacture of medicinal products as contract giver (H/V,I)
Record type Medicinal Products
Swissmedic record swissgmdp.ch

At a glance

  • No Licence active

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Swissmedic establishment licences

Swissmedic licenses establishments that manufacture, import, export or distribute medicinal products in Switzerland and records their GMP/GDP compliance status.

Source: Swissmedic, Swiss Agency for Therapeutic Products

Browse all Swissmedic establishment licences